SPAC Mergers Are Viable Funding Tools, But The Test Is Yet To Come

Performance Has Been Subpar For Most That Have Taken SPAC Route

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.